Leidos Australia Awarded Land 2110 Phase 1B Chemical, Biological, Radiological, Nuclear Defence (CBRND) Project
(Adelaide, Australia), Sept. 4, 2018 - Today, Leidos Australia confirmed that it received award of the contract for Land 2110 Phase 1B from the Australian Department of Defence. The total value of the contract is $243.5 million over the Acquisition and Initial Support phase of five years.
In partnership with the Capability Acquisition and Sustainment Group, Leidos will deliver critical capability to Defence in the area of Chemical, Biological, Radiological and Nuclear Defence (CBRND).
The primary objective of the joint CBRND capability is to provide Force Protection to deployed Australian Defence Force (ADF) personnel, assigned coalition personnel, and designated civilians, both offshore and within Australia, against extant and emerging CBRN threats including environmental hazards. Additional objectives of the ADF's CBRND capabilities are to enhance support to other government agencies in domestic CBRN incidents, and to assist integration in a coordinated whole of government effort.
The project will deliver and sustain capabilities in Detection, Identification and Monitoring, Warning and Reporting, Physical Protection, Hazard Management and Medical Support.
“Leidos has a long heritage of delivering complex logistics and CBRND capability globally, and we are delighted to be chosen to deliver this critical capability to the ADF,” said Christine Zeitz, Leidos Australia Chief Executive.
Leidos Australia has maximised Australian industry involvement to create local jobs through this important investment working with 14 Australian-based companies of which five are SMEs who will support capability delivery under the contract.
Forty new jobs will be created under the acquisition contract to support the Government’s Sovereign Industrial Capability Priority of Test, Evaluation, Certification and Systems’ Assurance, and will help to ensure a skilled and sustained Australian workforce to support Australia’s unique requirements. A further ten new jobs will be created to deliver the Initial Support Phase.
Further investment in technology refresh and capability enhancement is expected throughout the life of the contract. This will continue to create further opportunities for Australian industry in the future.
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 31,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.17 billion for the fiscal year ended December 29, 2017. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 29, 2017, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.